New therapeutic strategies for stiff heart failure
HRI has launched an international research project investigating new therapeutic strategies for stiff heart failure.
Dr Yen Chin Koay wins ISHR International Poster Prize
Dr Yen Chin Koay of HRI’s Cardiometabolic Disease Group was awarded the International Poster Prize at the XXIV World Congress International Society for Heart Research (ISHR) 2022, Berlin, Germany.
The Congenital Heart Fitness Intervention Trial bringing hope
HRI is embarking on “CH-FIT: The Congenital Heart Fitness Intervention Trial” to investigate the benefits of exercise for people with congenital heart disease.
Sepsis research accelerated by James N. Kirby Foundation Grant
Dr Christopher Stanley’s research focuses on cardiovascular decline seen in sepsis, also known as septic shock – for which there is no clinical treatment.
Is myeloperoxidase the key to preventing heart attack and stroke?
Dr James Nadel has published a literature review in Cardiovascular Research which explores the role of myeloperoxidase (MPO) in cardiovascular disease.
Leading Australian heart expert to improve Indigenous health
HRI's Prof Ben Freedman is taking part in a health screening program for atrial fibrillation and high blood pressure to improve Indigenous health.
World-first study to determine if exercise is bad or good for those with congenital heart disease
HRI's world-first exercise study led by Assoc Prof Rachael Cordina could revolutionise the way those with half a heart live their lives.
Why people with sleep apnoea develop high blood pressure and diabetes
Dr Melissa Farnham has been awarded a grant to investigate why people with obstructive sleep apnoea develop high blood pressure and diabetes.
HRI welcomes new Chair, The Hon Peter McGauran
HRI has appointed a new Chair, The Hon Peter McGauran, who is former Federal Science and Technology Minister, and has extensive experience working within the medical sector.